Previous reports have demonstrated that WFDC1 expression was dramatically downregulated in highly prolific mesenchymal cells and in a number of cancers, including fibrosarcomas, and in tumors of the lung, bladder, prostate, and brain [24]. The gene discussed is WFDC1; the disease is cancer.